Logo

oral cancer

Human Microbiome Analysis Opens Wide Array of Dx Opportunities, But Science Unsettled
Premium

Direct-to-consumer microbiome tests often go beyond what the research can support, but the large databases being generated by some companies are supporting diagnostic development.

Viome Life Sciences Raises $67M in Series C Financing

The firm said it has raised more than $150 million in total funding, and the new financing will support development of its assay product pipeline.

Viome Forays Outside Molecularly Informed DTC Wellness Testing With Oral Cancer Assay
Premium

The firm also hopes to use its metatranscriptomics approach to develop diagnostics and therapeutics for a variety of other disease areas.

HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals
Premium

Patients with discordant p16 and HPV markers fall into an intermediate risk group, research presented at the European cancer conference suggests.

Avalon GloboCare Using Exosome Isolation Platform to Pursue Oral Cancer Dx, Rx Applications
Premium

The firm is applying the isolation tool in cellular therapy for oral cancer by administering a biomarker via bioengineered exosomes to reverse cancer progression.

Oct 25, 2018

Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer
Premium

Jun 19, 2017

MDxHealth, Queensland University of Technology Collaborate on Oral Cancer Test

Nov 3, 2016

Tobacco Smoke Mutation Signatures Refined Through Sequencing Studies

Aug 29, 2016

Taiwan's iStat Biomedical Gets CE Mark for HPV-Associated Cancer Products

Sep 11, 2015

Launching Saliva Detection Test for Oral Cancer, PeriRx Sees Opportunity for Early-Stage Disease Dx
Premium

Jul 30, 2015

Study Finds Oral Cancer Prognostic Clues From Spit Samples With Persistent HPV16 DNA

Jul 15, 2015

Microfluidic Protein Array Shows Promise for Predicting Mucositis During Cancer Therapy
Premium

Aug 13, 2014

Oral Cancer MDx Firm Proteocyte Closes $554K Funding

Jan 17, 2014

LED Medical, BC Cancer Agency, Genome British Columbia to Develop Test for Oral Cancer

Mar 29, 2013

NIDCR to Fund Research into Basis of Oral Cancer Initiating Cells

May 1, 2012

UCSF, NYU Team on Oral Cancer Marker

Oct 19, 2011

Canadian Team Says Four-Gene Signature Could Predict Oral Cancer Recurrence, Improve on Histology
Premium

Oct 11, 2011

International Team Finds Predictive Gene Signature for Oral Cancer Recurrence

Feb 27, 2009

Outsourced Sequencing, Field Programmable Gate Arrays, Tissue Arrays, and Proteomics in the Clinic
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.